Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Recruiting · NCT06517888 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | Ear Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neurologic Manifestations, Otorhinolaryngologic Neoplasms, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, acoustic neuroma, cranial nerve neoplasm, cranial nerve neuropathy, hearing disorder, hearing loss disorder, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroma, otorhinolaryngologic disease, peripheral nervous system neoplasm, primitive neuroectodermal tumor, retrocochlear disease, schwannoma, vestibulocochlear nerve disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-06 | NCT06517888 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akouos, Inc. | 4 |
| Eli Lilly and Company | 370 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins Hospital | Baltimore | United States | 18 |
| Mayo Clinic | Rochester | United States | 664 |
| University of Texas Southwestern | Dallas | United States | 73 |
| Vanderbilt Bill Wilkerson Center | Nashville | United States | 2 |